First person profile: Mona Fouad, MD, MPH: Dr Fouad is credited for initiating and implementing programs throughout Alabama aimed at educating people about good health practices, the benefits of screening for early detection, and health literacy
This news section offers Cancer readers timely information on events, public policy analysis, topical issues, and personalities. In this issue, Mona Fouad, MD, MPH, demonstrates her perseverance for preventive health care through programs in Alabama aimed at educating people about good health practi...
Gespeichert in:
Veröffentlicht in: | Cancer 2024-04, Vol.130 (8), p.1190-1191 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1191 |
---|---|
container_issue | 8 |
container_start_page | 1190 |
container_title | Cancer |
container_volume | 130 |
creator | Nierengarten, Mary Beth |
description | This news section offers
Cancer
readers timely information on events, public policy analysis, topical issues, and personalities. In this issue, Mona Fouad, MD, MPH, demonstrates her perseverance for preventive health care through programs in Alabama aimed at educating people about good health practices, the benefits of screening, and health literacy. In addition, golidocitinib shows promising antitumor activity in patients with refractory or relapsed peripheral T‐cell lymphoma; and promising new treatment approaches for locally advanced cervical cancer are discussed. |
doi_str_mv | 10.1002/cncr.35271 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2968922267</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2959411301</sourcerecordid><originalsourceid>FETCH-LOGICAL-c189t-c2dba0f1dcc2cec9d44fb85fbbc4ef615f1656999140c447415ff480c0389df43</originalsourceid><addsrcrecordid>eNpdkk1v1DAQhiMEokvhwg9AI3FBaFNsx_lwb1XLUqRWcACJW-Q4411XiZ3azmF_eO84u0sPHCzL42cevbIny95TckEJYV-UVf6iKFlNX2QrSkSdE8rZy2xFCGnykhd_zrI3ITykY83K4nV2VjRcNKypVtnTxvgQYUIfnIXJO20GvIR7ZyVs3Cz7NdzfpPXz9hJu_LEEJoDy2JuIPWjnwVgTjYzGbkHadD1OA45oD4Wk3Ho5Bog77-btzs0RrgbZyVGCNGMyyAjYz-rYP6FLzSC7hds618MO5RB3ySNVNArDOpkQOrSoTQzgNIQUBu3SvYRB6Yc99Bgx8c6uD5FOkiFFTp792-yVlkPAd6f9PPu9-frr-ja_-_Ht-_XVXa5oI2KuWN9JommvFFOoRM-57ppSd53iqCtaalqVlRCCcqI4r3mqaN4QRYpG9JoX59mnoze9wuOMIbajCQqHQVp0c2iZqBrBGKvqhH78D31ws7cpXaJKwSktCE3U5yOlvAvBo24nb0bp9y0l7TIM7TIM7WEYEvzhpJy79NDP6L_fL_4C7c-0lA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2959411301</pqid></control><display><type>article</type><title>First person profile: Mona Fouad, MD, MPH: Dr Fouad is credited for initiating and implementing programs throughout Alabama aimed at educating people about good health practices, the benefits of screening for early detection, and health literacy</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Nierengarten, Mary Beth</creator><creatorcontrib>Nierengarten, Mary Beth</creatorcontrib><description>This news section offers
Cancer
readers timely information on events, public policy analysis, topical issues, and personalities. In this issue, Mona Fouad, MD, MPH, demonstrates her perseverance for preventive health care through programs in Alabama aimed at educating people about good health practices, the benefits of screening, and health literacy. In addition, golidocitinib shows promising antitumor activity in patients with refractory or relapsed peripheral T‐cell lymphoma; and promising new treatment approaches for locally advanced cervical cancer are discussed.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/cncr.35271</identifier><identifier>PMID: 38498286</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Alabama ; Anticancer properties ; Antitumor activity ; Cancer ; Cervical cancer ; Early Diagnosis ; Health Literacy ; Humans ; Lymphoma ; Policy analysis ; Public policy ; T-cell lymphoma</subject><ispartof>Cancer, 2024-04, Vol.130 (8), p.1190-1191</ispartof><rights>2024 American Cancer Society.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38498286$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nierengarten, Mary Beth</creatorcontrib><title>First person profile: Mona Fouad, MD, MPH: Dr Fouad is credited for initiating and implementing programs throughout Alabama aimed at educating people about good health practices, the benefits of screening for early detection, and health literacy</title><title>Cancer</title><addtitle>Cancer</addtitle><description>This news section offers
Cancer
readers timely information on events, public policy analysis, topical issues, and personalities. In this issue, Mona Fouad, MD, MPH, demonstrates her perseverance for preventive health care through programs in Alabama aimed at educating people about good health practices, the benefits of screening, and health literacy. In addition, golidocitinib shows promising antitumor activity in patients with refractory or relapsed peripheral T‐cell lymphoma; and promising new treatment approaches for locally advanced cervical cancer are discussed.</description><subject>Alabama</subject><subject>Anticancer properties</subject><subject>Antitumor activity</subject><subject>Cancer</subject><subject>Cervical cancer</subject><subject>Early Diagnosis</subject><subject>Health Literacy</subject><subject>Humans</subject><subject>Lymphoma</subject><subject>Policy analysis</subject><subject>Public policy</subject><subject>T-cell lymphoma</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkk1v1DAQhiMEokvhwg9AI3FBaFNsx_lwb1XLUqRWcACJW-Q4411XiZ3azmF_eO84u0sPHCzL42cevbIny95TckEJYV-UVf6iKFlNX2QrSkSdE8rZy2xFCGnykhd_zrI3ITykY83K4nV2VjRcNKypVtnTxvgQYUIfnIXJO20GvIR7ZyVs3Cz7NdzfpPXz9hJu_LEEJoDy2JuIPWjnwVgTjYzGbkHadD1OA45oD4Wk3Ho5Bog77-btzs0RrgbZyVGCNGMyyAjYz-rYP6FLzSC7hds618MO5RB3ySNVNArDOpkQOrSoTQzgNIQUBu3SvYRB6Yc99Bgx8c6uD5FOkiFFTp792-yVlkPAd6f9PPu9-frr-ja_-_Ht-_XVXa5oI2KuWN9JommvFFOoRM-57ppSd53iqCtaalqVlRCCcqI4r3mqaN4QRYpG9JoX59mnoze9wuOMIbajCQqHQVp0c2iZqBrBGKvqhH78D31ws7cpXaJKwSktCE3U5yOlvAvBo24nb0bp9y0l7TIM7TIM7WEYEvzhpJy79NDP6L_fL_4C7c-0lA</recordid><startdate>20240415</startdate><enddate>20240415</enddate><creator>Nierengarten, Mary Beth</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20240415</creationdate><title>First person profile: Mona Fouad, MD, MPH: Dr Fouad is credited for initiating and implementing programs throughout Alabama aimed at educating people about good health practices, the benefits of screening for early detection, and health literacy</title><author>Nierengarten, Mary Beth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c189t-c2dba0f1dcc2cec9d44fb85fbbc4ef615f1656999140c447415ff480c0389df43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Alabama</topic><topic>Anticancer properties</topic><topic>Antitumor activity</topic><topic>Cancer</topic><topic>Cervical cancer</topic><topic>Early Diagnosis</topic><topic>Health Literacy</topic><topic>Humans</topic><topic>Lymphoma</topic><topic>Policy analysis</topic><topic>Public policy</topic><topic>T-cell lymphoma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nierengarten, Mary Beth</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nierengarten, Mary Beth</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>First person profile: Mona Fouad, MD, MPH: Dr Fouad is credited for initiating and implementing programs throughout Alabama aimed at educating people about good health practices, the benefits of screening for early detection, and health literacy</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>2024-04-15</date><risdate>2024</risdate><volume>130</volume><issue>8</issue><spage>1190</spage><epage>1191</epage><pages>1190-1191</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>This news section offers
Cancer
readers timely information on events, public policy analysis, topical issues, and personalities. In this issue, Mona Fouad, MD, MPH, demonstrates her perseverance for preventive health care through programs in Alabama aimed at educating people about good health practices, the benefits of screening, and health literacy. In addition, golidocitinib shows promising antitumor activity in patients with refractory or relapsed peripheral T‐cell lymphoma; and promising new treatment approaches for locally advanced cervical cancer are discussed.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>38498286</pmid><doi>10.1002/cncr.35271</doi><tpages>2</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-543X |
ispartof | Cancer, 2024-04, Vol.130 (8), p.1190-1191 |
issn | 0008-543X 1097-0142 |
language | eng |
recordid | cdi_proquest_miscellaneous_2968922267 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Alabama Anticancer properties Antitumor activity Cancer Cervical cancer Early Diagnosis Health Literacy Humans Lymphoma Policy analysis Public policy T-cell lymphoma |
title | First person profile: Mona Fouad, MD, MPH: Dr Fouad is credited for initiating and implementing programs throughout Alabama aimed at educating people about good health practices, the benefits of screening for early detection, and health literacy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T13%3A46%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=First%20person%20profile:%20Mona%20Fouad,%20MD,%20MPH:%20Dr%20Fouad%20is%20credited%20for%20initiating%20and%20implementing%20programs%20throughout%20Alabama%20aimed%20at%20educating%20people%20about%20good%20health%20practices,%20the%20benefits%20of%20screening%20for%20early%20detection,%20and%20health%20literacy&rft.jtitle=Cancer&rft.au=Nierengarten,%20Mary%20Beth&rft.date=2024-04-15&rft.volume=130&rft.issue=8&rft.spage=1190&rft.epage=1191&rft.pages=1190-1191&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/cncr.35271&rft_dat=%3Cproquest_cross%3E2959411301%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2959411301&rft_id=info:pmid/38498286&rfr_iscdi=true |